VJHemOnc is committed to improving our service to you

ASH 2019 | Predictors of early relapse in transplant-eligible MM patients

VJHemOnc is committed to improving our service to you

Francesca Gay

Francesca Gay, MD, PhD, University of Turin, Turin, Italy, discusses the integrative analysis of baseline prognostic features and achievement of measurable residual disease (MRD) negativity in an attempt to identify the main predictors of early relapse in transplant-eligible multiple myeloma (MM) patients. This interview took place at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter